The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

DYN FINANCIAL STATEMENTS

Dyne Therapeutics Inc — balance sheet, income statement and cash flow trends

DYNDyne Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-400 M-200 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-1.1 M $ · -Infinity%Operating Income-537 M $ · -Infinity%Pre-tax Income-519.4 M $ · -Infinity%Net Income to Owners-519.4 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-1.1 M $—
Operating Income-537 M $—
EBITDA-495.3 M $—
Net Income to Owners-519.4 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets994 M
  • Equity702.2 M $71%
  • Current Liabilities78 M $8%
  • Long-term Liabilities213.8 M $22%

Key Figures

YoY change
Total Assets994 M $+36.4%
Total Liabilities291.9 M $+85.3%
Total Equity702.2 M $+22.9%
Cash & ST Investments898.5 M $+31.4%
Total Debt19.9 M $-83.6%
Net Debt-656.2 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-400 M-200 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-400 M-200 M0200 M-477.8 M $Operating-44.2 M $Investing713.5 M $Financing191.5 M $Net Change

Key Figures

YoY change
Operating Cash Flow-477.8 M $—
Capital Expenditures21.4 M $+803.5%
Free Cash Flow-499.2 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on DYN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.